Data Snapshot: Nov 03, 2026
$100K+

Oct-2026

Sales

Growth

Trend

6-Month

27

Product Count

SKUs

$25.18

Avg Price

26.7%

YoY Sales Change

-15.4%

YoY Price Change

How loyal are cannabis customers to the brands they buy? See retention benchmarks by category and state →
For brands

Is this your brand?

See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.

See your brand's data
For retailers

Carry this brand in your store?

Headset Retailer is free. Connect your POS and see what's selling and what's sitting.

Sign up free
Beneleaves

Where to Buy

Beneleaves is stocked at 91 licensed dispensaries across Ohio, with the deepest coverage in Columbus, Cincinnati, Dayton, Cleveland, and Marietta. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/11915.json?v=20261102
Beneleaves Sales

Market Insights Snapshot

Beneleaves Historical Sales by Category

In October 2026, Beneleaves concentrated 90.88% of sales in Capsules with year-over-year growth of 29.18% and month-over-month growth of 2.70%, while Topical held 6.81% share with 25.11% YoY and a -2.64% MoM dip. Edible remained a small 0.78% slice despite a 90.73% YoY surge but contracted -71.78% MoM, and Vapor Pens accounted for 0.38% with -85.84% YoY and -14.05% MoM. With overall brand sales up 26.73% YoY and average price down 15.44%, the mix pattern implies Capsules-led volume gain supported by price elasticity, while volatility in Edible and ongoing contraction in Vapor Pens limit diversification.

The category tilt places Beneleaves as a mono-core Capsules player, reinforced by a number 1 rank in Capsules in Ohio, but the -15.44% YoY price move suggests the leadership relies on accessible pricing rather than breadth, as Topical’s -2.64% MoM and Vapor Pens’ -14.05% MoM signal weak adjacent traction. The juxtaposition of a 2.70% MoM lift in Capsules against a -71.78% MoM collapse in Edible indicates share consolidation around the flagship rather than portfolio expansion, implying future positioning should deepen Capsules differentiation while selectively pruning underperforming extensions.

Oct-2026 Rank
Capsules
Topical
#1
#6
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Capsules
90.9%
$25.38
+29.2%
+2.7%
Topical
6.8%
$24.57
+25.1%
-2.6%
Edible
0.8%
$18.01
+90.7%
-71.8%
Vapor Pens
0.4%
$36.42
-85.8%
-14.0%
Beneleaves

Competitive Landscape

Beneleaves is ranked #1 in OH Capsules in October 2026, unchanged from #1 a year earlier, and it held #1 three months ago as well, while UB GOOD sits at #2 now and was #2 year over year despite a 75.9% sales lift, and Main Street Health remains #3 with a 51.6% YoY sales increase; in contrast, Butterfly Effect - Grow Ohio held at #4 with a 4.7% YoY gain, indicating competitors are climbing in sales but not dislodging ranks, so the flat rank spread (#1 through #4 unchanged YoY) implies a stable hierarchy where Beneleaves’ sustained #1 position depends more on relative pacing than on absolute growth dollars.

Beneleaves category ranking vs. nearest competitors
Beneleaves

Notable Products

Beneleaves is heavily concentrated in capsules in October 2026, with Hybrid, Sativa, Indica, and CBD/CBN capsules totaling 90.9% of sales, and the top 10 items accounting for 90.6%. Two capsule SKUs, Hybrid RSO Capsules 22-Pack (660mg) at 22.6% and Sativa Helios Capsules 11-Pack (440mg) at 22.3%, together approach half the brand’s sales, so most of its sales ride on a few capsule formats.

Product
Type
Share of Sales
Avg Price
vs. Peer Avg
MoM %
Hybrid RSO Capsules 22-Pack (660mg)
Hybrid
22.6%
$28.27
+0.0%
-40.1%
Sativa Helios Capsules 11-Pack (440mg)
Sativa
22.3%
$32.53
+0.0%
+37.5%
Indica Hypnos Capsules 11-Pack (440mg)
Indica
14.0%
$33.69
-1.9%
+52.4%
CBD/THC/CBG/CBC/CBN Entourage Effect Capsules 22-Pack (110mg CBD, 220mg THC, 339mg CBG, 321mg CBN, 303mg CBC)
Hybrid
8.6%
$17.93
-0.1%
+24.4%
CBN/THC 1:1 Hypnos Capsules 22-Pack (220mg CBN, 220mg THC)
CBD / CBN
4.9%
$17.74
-3.4%
+37.6%
Hybrid Unflavored RSO Capsules 11-Pack (110mg)
Hybrid
4.8%
$14.49
+41.0%
+111.8%
THC/CBG 1:1 Sativa Helios Capsules 22-Pack (220mg THC, 220mg CBG)
CBD / CBN
4.4%
$18.46
+0.5%
+22.5%
Lavender Provence Lotion (295mg THC, 3oz)
Lotion, Salves, Gels, and Creams
3.2%
$21.51
-32.4%
+41.2%
CBD/THC/CBN 25:40:11 Hypnos + CBN Capsules 11-Pack (275mg CBD, 440mg THC, 121mg CBN)
CBD / CBN
2.9%
$36.28
-1.5%
+31.3%
CBG/THC 1:1 Hypnos Wintergreen Lotion (295mg CBG, 295mg THC, 3oz)
Lotion, Salves, Gels, and Creams
2.9%
$29.93
-6.0%
-14.7%

Peer avg: average price of the same product type and package size in the same states that month.

View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market